IL-17 integrates multiple self-reinforcing, feed-forward mechanisms through the RNA-binding protein Arid5a
Open accessThe DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Abstract
). These TFs in turn transactivated IL-17-dependent promoters. Together, these data indicated that Arid5a orchestrates a feed-forward amplification loop, which promoted IL-17 signaling by controlling mRNA stability and translation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Regnase-1 binds to IL-17- and LPS-induced gene transcripts via stem-loop structures in the 3’ UTR in a site overlapping with Arid5a, another IL-17-induced RBP”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Amatya et al., 2018
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Rather, IL-17 employs the RBPs HuR and Arid5a to prolong the half-life of certain target transcripts.”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Amatya et al., 2018
In the citing paper
“The IL-17-driven pathway that controls RNA stability is initiated by phosphorylation of Act1 by Ikki (IKKe), directing its association to TRAF2 and TRAF5. and mobilizing multiple RBPs”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Amatya et al., 2018
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099
The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing
Gaffen, S. L., Jain, R., Garg, A. V., & Cua, D. J. (2014) · Nature reviews. Immunology · doi:10.1038/nri3707 · Cited by 1,585
Self-citationInnate IL-17-producing cells: the sentinels of the immune system
Cua, D. J., & Tato, C. M. (2010) · Nature Reviews Immunology · doi:10.1038/nri2800 · Cited by 1,578
Functional Specialization of Interleukin-17 Family Members
Iwakura, Y., Ishigame, H., Saijo, S., & Nakae, S. (2011) · Immunity · doi:10.1016/j.immuni.2011.02.012 · Cited by 1,289 · cited 2×
“DISCUSSION IL-17 signaling dominantly occurs in epithelial and mesenchymal cell types (39), and thus, IL-17 functions as a bridge between the immune system and inflamed tissue.”
BackgroundDickson, M. A., Hahn, W. C., Ino, Y., Ronfard, V., Wu, J. Y., Weinberg, R. A., Louis, D. N., Li, F. P., & Rheinwald, J. G. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.4.1436-1447.2000 · Cited by 1,104
Conti, H. R., Shen, F., Nayyar, N., Stocum, E., Sun, J. N., Lindemann, M. J., Ho, A. W., Hai, J. H., Yu, J. J., Jung, J. W., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20081463 · Cited by 1,024 · cited 2×
“albicans (CAF2-1) for 75 min under anesthesia (23).”
BackgroundSelf-citationBrodalumab, an Anti–Interleukin-17–Receptor Antibody for Psoriasis
Papp, K. A., Leonardi, C., Menter, A., Ortonne, J.-P., Krueger, J. G., Kricorian, G., Aras, G., Li, J., Russell, C. B., Thompson, E. H. Z., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1109017 · Cited by 941 · cited 1×
“Blocking IL-17 is remarkably effective in treating psoriasis and is under evaluation for other autoimmune conditions (59, 60).”
Anti–Interleukin-17 Monoclonal Antibody Ixekizumab in Chronic Plaque Psoriasis
Leonardi, C., Matheson, R., Zachariae, C., Cameron, G., Li, L., Edson-Heredia, E., Braun, D., & Banerjee, S. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1109997 · Cited by 936 · cited 1×
“Blocking IL-17 is remarkably effective in treating psoriasis and is under evaluation for other autoimmune conditions (59, 60).”
BackgroundInterleukin-17 and its target genes: mechanisms of interleukin-17 function in disease
Onishi, R. M., & Gaffen, S. L. (2010) · Immunology · doi:10.1111/j.1365-2567.2009.03240.x · Cited by 894
Self-citationCrooke, S. T., Witztum, J. L., Bennett, C. F., & Baker, B. F. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.03.004 · Cited by 841
IL-17 Signaling: The Yin and the Yang
Amatya, N., Garg, A. V., & Gaffen, S. L. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.01.006 · Cited by 785
Self-citationBleomycin and IL-1β–mediated pulmonary fibrosis is IL-17A dependent
Wilson, M. S., Madala, S. K., Ramalingam, T. R., Gochuico, B. R., Rosas, I. O., Cheever, A. W., & Wynn, T. A. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20092121 · Cited by 730
Zc3h12a is an RNase essential for controlling immune responses by regulating mRNA decay
Matsushita, K., Takeuchi, O., Standley, D. M., Kumagai, Y., Kawagoe, T., Miyake, T., Satoh, T., Kato, H., Tsujimura, T., Nakamura, H., et al. (2009) · Nature · doi:10.1038/nature07924 · Cited by 649 · cited 1×
“Control expression of either Act1 enhanced Il6 3′UTR reporter activity, whereas MCPIP1 suppressed activity, as expected (28, 29).”
BackgroundIL-17 family: Cytokines, receptors and signaling
Gu, C., Wu, L., & Li, X. (2013) · Cytokine · doi:10.1016/j.cyto.2013.07.022 · Cited by 595
Lymphoproliferative disorder and imbalanced T-helper response in C/EBP beta-deficient mice
Screpanti, I., Romani, L., Musiani, P., Modesti, A., Fattori, E., Lazzaro, D., Sellitto, C., Scarpa, S., Bellavia, D., & Lattanzio, G. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07185.x · Cited by 407
Mino, T., Murakawa, Y., Fukao, A., Vandenbon, A., Wessels, H.-H., Ori, D., Uehata, T., Tartey, S., Akira, S., Suzuki, Y., et al. (2015) · Cell · doi:10.1016/j.cell.2015.04.029 · Cited by 390 · cited 1×
“In the setting of lipopolysaccharide signaling in macrophages, Arid5a and MCPIP1 bind to an overlapping RNA binding sequence on the Il6 3′UTR (24, 46).”
BackgroundPost-transcriptional control of cytokine production
Anderson, P. (2008) · Nature Immunology · doi:10.1038/ni1584 · Cited by 376 · cited 2×
“Many IL-17–induced transcripts have adenylate-uridylate–rich elements or other stability-determining sequences in the 3′ untranslated region (3′UTR) (17).”
BackgroundRuddy, M. J., Wong, G. C., Liu, X. K., Yamamoto, H., Kasayama, S., Kirkwood, K. L., & Gaffen, S. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308809200 · Cited by 364 · cited 5×
“IL-17 enhanced Cebpb and Nfkbiz mRNA, albeit modestly (7, 56), whereas concomitant protein expression of both TFs was profoundly increased.”
InfluentialSelf-citationIL-17–Mediated Immunity to the Opportunistic Fungal Pathogen Candida albicans
Conti, H. R., & Gaffen, S. L. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500909 · Cited by 301 · cited 1×
“INTRODUCTION Interleukin-17A (IL-17) is an inflammatory cytokine that is crucial for host defense against microbial pathogens, particularly fungi such as the opportunistic fungus Candida albicans (1).”
Self-citationIdentification of Common Transcriptional Regulatory Elements in Interleukin-17 Target Genes
Shen, F., Hu, Z., Goswami, J., & Gaffen, S. L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604597200 · Cited by 294
Self-citationA Strategy for Modulation of Enzymes in the Ubiquitin System
Ernst, A., Avvakumov, G., Tong, J., Fan, Y., Zhao, Y., Alberts, P., Persaud, A., Walker, J. R., Neculai, A.-M., Neculai, D., et al. (2013) · Science · doi:10.1126/science.1230161 · Cited by 283 · cited 1×
“Hence, defining the molecular basis of IL-17 signal transduction may inform therapeutic strategies for diseases where IL-17 is implicated (61).”
BackgroundIL-17 Enhances Chemokine Gene Expression through mRNA Stabilization
Hartupee, J., Liu, C., Novotny, M., Li, X., & Hamilton, T. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.6.4135 · Cited by 282
Jeltsch, K. M., Hu, D., Brenner, S., Zöller, J., Heinz, G. A., Nagel, D., Vogel, K. U., Rehage, N., Warth, S. C., Edelmann, S. L., et al. (2014) · Nature Immunology · doi:10.1038/ni.3008 · Cited by 274
Shen, F., Ruddy, M. J., Plamondon, P., & Gaffen, S. L. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0904490 · Cited by 268 · cited 14×
“IL-17 signaling in culture systems is typically modest compared to potent inflammatory stimuli such as TNF (2, 7).”
InfluentialSelf-citationIκBζ regulates TH17 development by cooperating with ROR nuclear receptors
Okamoto, K., Iwai, Y., Oh-hora, M., Yamamoto, M., Morio, T., Aoki, K., Ohya, K., Jetten, A. M., Akira, S., Muta, T., et al. (2010) · Nature · doi:10.1038/nature08922 · Cited by 265
Cortez, D. M., Feldman, M. D., Mummidi, S., Valente, A. J., Steffensen, B., Vincenti, M., Barnes, J. L., & Chandrasekar, B. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00928.2007 · Cited by 241
Sun, D., Novotny, M., Bulek, K., Liu, C., Li, X., & Hamilton, T. (2011) · Nature Immunology · doi:10.1038/ni.2081 · Cited by 232
Arid5a controls IL-6 mRNA stability, which contributes to elevation of IL-6 level in vivo
Masuda, K., Ripley, B., Nishimura, R., Mino, T., Takeuchi, O., Shioi, G., Kiyonari, H., & Kishimoto, T. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1307419110 · Cited by 226 · cited 9×
“In addition, Arid5a is linked to TH17 cell differentiation through stabilization of Il6, Stat3, and Ox40 in antigen-presenting cells or T cells (24, 40, 51, 52) and thus may enhance IL-17–dependent mRNA stability mRNA translation”
BackgroundMethodInfluentialRuddy, M. J., Shen, F., Smith, J. B., Sharma, A., & Gaffen, S. L. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0204065 · Cited by 206
Self-citationImmortalized N/TERT keratinocytes as an alternative cell source in 3D human epidermal models
Smits, J. P. H., Niehues, H., Rikken, G., van Vlijmen-Willems, I. M. J. J., van de Zande, G. W. H. J. F., Zeeuwen, P. L. J. M., Schalkwijk, J., & van den Bogaard, E. H. (2017) · Scientific Reports · doi:10.1038/s41598-017-12041-y · Cited by 205
Patel, D. N., King, C. A., Bailey, S. R., Holt, J. W., Venkatachalam, K., Agrawal, A., Valente, A. J., & Chandrasekar, B. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703250200 · Cited by 197 · cited 1×
“However, the mechanisms underlying translational control of these proteins have been elusive (30, 32, 36, 57).”
Bulek, K., Liu, C., Swaidani, S., Wang, L., Page, R. C., Gulen, M. F., Herjan, T., Abbadi, A., Qian, W., Sun, D., et al. (2011) · Nature Immunology · doi:10.1038/ni.2080 · Cited by 192
TLR4-induced NF-κB and MAPK signaling regulate the IL-6 mRNA stabilizing protein Arid5a
Nyati, K. K., Masuda, K., Zaman, M. M.-U., Dubey, P. K., Millrine, D., Chalise, J. P., Higa, M., Li, S., Standley, D. M., Saito, K., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx064 · Cited by 190 · cited 2×
“In addition, Arid5a is linked to TH17 cell differentiation through stabilization of Il6, Stat3, and Ox40 in antigen-presenting cells or T cells (24, 40, 51, 52) and thus may enhance IL-17–dependent mRNA stability mRNA translation”
Eickelberg, O., Pansky, A., Mussmann, R., Bihl, M., Tamm, M., Hildebrand, P., Perruchoud, A. P., & Roth, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.18.12933 · Cited by 185
La-related protein 1 (LARP1) binds the mRNA cap, blocking eIF4F assembly on TOP mRNAs
Lahr, R. M., Fonseca, B. D., Ciotti, G. E., Al-Ashtal, H. A., Jia, J.-J., Niklaus, M. R., Blagden, S. P., Alain, T., & Berman, A. J. (2017) · eLife · doi:10.7554/elife.24146 · Cited by 185 · cited 4×
“S. L. Gaffen, S. Y. Lai, W. Xu, F. Gouilleux, B. Groner, M. A. Goldsmith, W. C. Greene, Signaling through the IL-2R b chain activates a STAT-5-like DNA binding activity.”
MethodInfluentialSelf-citationPost-transcriptional coordination of immunological responses by RNA-binding proteins
Kafasla, P., Skliris, A., & Kontoyiannis, D. L. (2014) · Nature Immunology · doi:10.1038/ni.2884 · Cited by 180
Maitra, A., Shen, F., Hanel, W., Mossman, K., Tocker, J., Swart, D., & Gaffen, S. L. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611589104 · Cited by 165
Self-citationIL-17-induced NF-κB Activation via CIKS/Act1
Sønder, S. U., Saret, S., Tang, W., Sturdevant, D. E., Porcella, S. F., & Siebenlist, U. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.199547 · Cited by 146
Karlsen, J. R., Borregaard, N., & Cowland, J. B. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.017129 · Cited by 146 · cited 2×
“The molecular basis for synergy is not fully understood but is mediated, in part, through cooperative activation of IL-17–induced TFs that activate downstream genes (9, 10).”
Mucocutaneous IL-17 immunity in mice and humans: host defense vs. excessive inflammation
Li, J., Casanova, J.-L., & Puel, A. (2018) · Mucosal Immunology · doi:10.1038/mi.2017.97 · Cited by 146
Garg, A. V., Amatya, N., Chen, K., Cruz, J. A., Grover, P., Whibley, N., Conti, H. R., Hernandez Mir, G., Sirakova, T., Childs, E. C., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.07.021 · Cited by 145
Self-citationIL-6 Secretion by Human Pancreatic Periacinar Myofibroblasts in Response to Inflammatory Mediators
Shimada, M., Andoh, A., Hata, K., Tasaki, K., Araki, Y., Fujiyama, Y., & Bamba, T. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.2.861 · Cited by 142 · cited 1×
“IL-17 increases Il6 expression both through acting on its proximal promoter and by stabilizing its mRNA transcript (7, 25, 26).”
BackgroundIκBζ is a key driver in the development of psoriasis
Johansen, C., Mose, M., Ommen, P., Bertelsen, T., Vinter, H., Hailfinger, S., Lorscheid, S., Schulze-Osthoff, K., & Iversen, L. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1509971112 · Cited by 125 · cited 2×
“For example, Arid5a−/−, Cebpb−/−, and Nfkbiz−/− mice are all refractory to EAE (24, 54, 55), and Nfkbiz−/− mice are also resistant to imiquimod-induced inflammation, a model representing psoriasislike IL-17–dependent skin inflammation (35).”
Herjan, T., Hong, L., Bubenik, J., Bulek, K., Qian, W., Liu, C., Li, X., Chen, X., Yang, H., Ouyang, S., et al. (2018) · Nature Immunology · doi:10.1038/s41590-018-0071-9 · Cited by 121 · cited 8×
“Rather, RBPs such as HuR, DDX3X, and Act1 serve to stabilize IL-17– dependent transcripts in a pathway initiated by TRAF2 and TRAF5 (19, 20, 28).”
BackgroundInfluentialMaekawa, T., Hosur, K., Abe, T., Kantarci, A., Ziogas, A., Wang, B., Van Dyke, T. E., Chavakis, T., & Hajishengallis, G. (2015) · Nature Communications · doi:10.1038/ncomms9272 · Cited by 119
IL-17A augments TNF-α–induced IL-6 expression in airway smooth muscle by enhancing mRNA stability
Henness, S., Johnson, C. K., Ge, Q., Armour, C. L., Hughes, J. M., & Ammit, A. J. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.06.023 · Cited by 99 · cited 2×
“As previously reported, IL-17 reduced decay of Il6 transcripts (26), but Il6 stabilization was impaired upon Arid5a knockdown (Fig.”
HuR is required for IL-17-induced Act1-mediated CXCL1 and CXCL5 mRNA stabilization
Herjan, T., Yao, P., Qian, W., Li, X., Liu, C., Bulek, K., Sun, D., Yang, W.-P., Zhu, J., He, A., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203315 · Cited by 95 · cited 12×
“Rather, RBPs such as HuR, DDX3X, and Act1 serve to stabilize IL-17– dependent transcripts in a pathway initiated by TRAF2 and TRAF5 (19, 20, 28).”
BackgroundInfluentialGaffen, S. L., Lai, S. Y., Xu, W., Gouilleux, F., Groner, B., Goldsmith, M. A., & Greene, W. C. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.16.7192 · Cited by 93
Self-citationIL‐17A deficiency mitigates bleomycin‐induced complement activation during lung fibrosis
Cipolla, E., Fisher, A. J., Gu, H., Mickler, E. A., Agarwal, M., Wilke, C. A., Kim, K. K., Moore, B. B., & Vittal, R. (2017) · The FASEB Journal · doi:10.1096/fj.201700289r · Cited by 89
IL-17 Signaling for mRNA Stabilization Does Not Require TNF Receptor-Associated Factor 6
Hartupee, J., Liu, C., Novotny, M., Sun, D., Li, X., & Hamilton, T. A. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.3.1660 · Cited by 88
Arid5a regulates naive CD4+ T cell fate through selective stabilization of Stat3 mRNA
Masuda, K., Ripley, B., Nyati, K. K., Dubey, P. K., Zaman, M. M.-U., Hanieh, H., Higa, M., Yamashita, K., Standley, D. M., Mashima, T., et al. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20151289 · Cited by 88 · cited 2×
“In addition, Arid5a is linked to TH17 cell differentiation through stabilization of Il6, Stat3, and Ox40 in antigen-presenting cells or T cells (24, 40, 51, 52) and thus may enhance IL-17–dependent mRNA stability mRNA translation”
BackgroundFaour, W. H., Mancini, A., He, Q. W., & Di Battista, J. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212790200 · Cited by 86
IL-17 regulates CXCL1 mRNA stability via an AUUUA/tristetraprolin-independent sequence
Datta, S., Novotny, M., Pavicic, P. G., Zhao, C., Herjan, T., Hartupee, J., & Hamilton, T. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902423 · Cited by 82
MCPIP1/Regnase-1 Restricts IL-17A- and IL-17C-Dependent Skin Inflammation
Monin, L., Gudjonsson, J. E., Childs, E. E., Amatya, N., Xing, X., Verma, A. H., Coleman, B. M., Garg, A. V., Killeen, M., Mathers, A., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601551 · Cited by 82
Self-citationMuromoto, R., Hirao, T., Tawa, K., Hirashima, K., Kon, S., Kitai, Y., & Matsuda, T. (2016) · International Immunology · doi:10.1093/intimm/dxw011 · Cited by 76
p38α Stabilizes Interleukin-6 mRNA via Multiple AU-richElements
Zhao, W., Liu, M., & Kirkwood, K. L. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707573200 · Cited by 72 · cited 2×
“When we cotransfected HEK293T cells with Arid5a and a luciferase reporter fused to the Il6 3′UTR (27), expression of Arid5a increased luciferase activity (Fig.”
Johansen, C., Bertelsen, T., Ljungberg, C., Mose, M., & Iversen, L. (2016) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.04.012 · Cited by 61
Higa, M., Oka, M., Fujihara, Y., Masuda, K., Yoneda, Y., & Kishimoto, T. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1719921115 · Cited by 61 · cited 1×
“Arid5a is highly expressed in the nucleus, but TLR4 signaling induces its translocation to the cytoplasm (58).”
BackgroundHanieh, H., Masuda, K., Metwally, H., Chalise, J. P., Mohamed, M. E., Nyati, K. K., Standley, D. M., Li, S., Higa, M., Zaman, M. M.-U., et al. (2017) · European Journal of Immunology · doi:10.1002/eji.201747109 · Cited by 47
Diversity in post-transcriptional control of neutrophil chemoattractant cytokine gene expression
Hamilton, T., Novotny, M., Pavicic, P. J., Herjan, T., Hartupee, J., Sun, D., Zhao, C., & Datta, S. (2010) · Cytokine · doi:10.1016/j.cyto.2010.04.003 · Cited by 36 · cited 2×
“IL-17 promotes mRNA stabilization of numerous genes, including Il6, C-X-C motif chemokine ligand 1 (Cxcl1), and Cxcl5 among others (16).”
BackgroundCIKS/DDX3X Interaction Controls the Stability of the Zc3h12a mRNA Induced by IL-17
Somma, D., Mastrovito, P., Grieco, M., Lavorgna, A., Pignalosa, A., Formisano, L., Salzano, A. M., Scaloni, A., Pacifico, F., Siebenlist, U., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1401589 · Cited by 36 · cited 8×
“Rather, RBPs such as HuR, DDX3X, and Act1 serve to stabilize IL-17– dependent transcripts in a pathway initiated by TRAF2 and TRAF5 (19, 20, 28).”
BackgroundInfluentialDhamija, S., Winzen, R., Doerrie, A., Behrens, G., Kühne, N., Schauerte, C., Neumann, E., Dittrich‐Breiholz, O., Kracht, M., & Holtmann, H. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.452649 · Cited by 28 · cited 2×
“However, the mechanisms underlying translational control of these proteins have been elusive (30, 32, 36, 57).”
BackgroundResultSønder, S. U., Paun, A., Ha, H.-L., Johnson, P. F., & Siebenlist, U. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103233 · Cited by 27
Arid5a-deficient mice are highly resistant to bleomycin-induced lung injury
Dubey, P. K., Masuda, K., Nyati, K. K., Zaman, M. M.-U., Chalise, J. P., Millrine, D., Wang, K., Ripley, B., & Kishimoto, T. (2017) · International Immunology · doi:10.1093/intimm/dxx004 · Cited by 25
Cited by
The IL-17 Family of Cytokines in Health and Disease
McGeachy, M. J., Cua, D. J., & Gaffen, S. L. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.021 · Cited by 1,443
“These RBPs bind 3’ UTR motifs and counteracting the activity of de-stabilizing ribonucleases (see below) (Amatya et al., 2018; Herjan et al., 2013; Puel and Casanova, 2018).”
BackgroundInfluentialSelf-citationIL-17 receptor–based signaling and implications for disease
Li, X., Bechara, R., Zhao, J., McGeachy, M. J., & Gaffen, S. L. (2019) · Nature Immunology · doi:10.1038/s41590-019-0514-y · Cited by 548
Self-citationThe IL-17 family in diseases: from bench to bedside
Huangfu, L., Li, R., Huang, Y., & Wang, S. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01620-3 · Cited by 452
Historical overview of the interleukin-6 family cytokine
Kang, S., Narazaki, M., Metwally, H., & Kishimoto, T. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20190347 · Cited by 360
The role of interleukin-17 in tumor development and progression
Zhao, J., Chen, X., Herjan, T., & Li, X. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20190297 · Cited by 248
“…regions that can be recognized by RNA-binding proteins (e.g., SF2) and mediate the sequential deadenylation, decapping, and ultimately exonucleolytic degradation of the RNA (Amatya et al., 2018; Bulek et al., 2011; Garg et al., 2015; Herjan et al., 2013, 2018; Somma et al., 2015; Sun et al., 2011).”
Background
Metadata
- Authors
- Amatya, N., Childs, E. E., Cruz, J. A., Aggor, F. E. Y., Garg, A. V., Berman, A. J., Gudjonsson, J. E., Atasoy, U., & Gaffen, S. L.
- Affiliations
- University of Pittsburgh (US)
- University of Michigan (US)
- Corresponding author
- Gaffen, Sarah L.
- ORCID
- Venue
- Science Signaling
- Published
- 2018-10-09
- Volume
- 11
- Issue
- 551
- ISSN
- 1937-9145 (ISSN-L)
- 1945-0877
- PMC
- PMC6188668
- OpenAlex
- W2896648763
- Cited by
- 75
- References
- 64
- Citations by year
- 2026: 8 · 2025: 6 · 2024: 12 · 2023: 7 · 2022: 13 · 2021: 8 · 2020: 9 · 2019: 11 · 2018: 1
- FWCI
- 3.12
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science Signaling (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of General Medical Sciences (GM116889)
- National Institute of Allergy and Infectious Diseases (AI107825, AI080870, AI128991)
- National Institute of Dental and Craniofacial Research (DE022550, DE023815)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- IL-17 signaling, Arid5a, RNA-binding proteins, feed-forward loop, self-reinforcing mechanisms, mRNA stability, translational regulation
- MeSH terms
- Animals, DNA-Binding Proteins, Fibroblasts, Humans, Inflammation, Mice, Inbred C57BL, Nuclear Proteins, Protein Binding, Ribonucleases, RNA, Messenger, Transcription Factors, Signal Transduction, Keratinocytes, Cytokines, RNA-Binding Proteins, Mice, Knockout, Interleukin-17, 3' Untranslated Regions, CCAAT-Enhancer-Binding Protein-beta, TNF Receptor-Associated Factor 2, Adaptor Proteins, Signal Transducing, Mice, HEK293 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.